zokinvy
Generic: lonafarnib
Labeler: sentynl therapeutics, inc.Drug Facts
Product Profile
Brand Name
zokinvy
Generic Name
lonafarnib
Labeler
sentynl therapeutics, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
lonafarnib 75 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42358-475
Product ID
42358-475_027cd79f-a9a2-4038-9296-1f85299b55c5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA213969
Listing Expiration
2027-12-31
Marketing Start
2025-07-02
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42358475
Hyphenated Format
42358-475
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zokinvy (source: ndc)
Generic Name
lonafarnib (source: ndc)
Application Number
NDA213969 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 75 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (42358-475-30) / 30 CAPSULE in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "027cd79f-a9a2-4038-9296-1f85299b55c5", "openfda": {"nui": ["N0000193938", "N0000193939", "N0000187062", "N0000190114", "N0000185503", "N0000182140", "N0000190107", "N0000190108", "N0000190113"], "upc": ["0342358450305", "0342358475308"], "unii": ["IOW153004F"], "rxcui": ["2467582", "2467588", "2467590", "2467592"], "spl_set_id": ["97391d0c-943e-4c5a-8423-68e163aa7f50"], "pharm_class_epc": ["Farnesyltransferase Inhibitor [EPC]"], "pharm_class_moa": ["Farnesyltransferase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Sentynl Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (42358-475-30) / 30 CAPSULE in 1 BOTTLE, PLASTIC", "package_ndc": "42358-475-30", "marketing_start_date": "20250702"}], "brand_name": "Zokinvy", "product_id": "42358-475_027cd79f-a9a2-4038-9296-1f85299b55c5", "dosage_form": "CAPSULE", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Farnesyltransferase Inhibitor [EPC]", "Farnesyltransferase Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "42358-475", "generic_name": "lonafarnib", "labeler_name": "Sentynl Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zokinvy", "active_ingredients": [{"name": "LONAFARNIB", "strength": "75 mg/1"}], "application_number": "NDA213969", "marketing_category": "NDA", "marketing_start_date": "20250702", "listing_expiration_date": "20271231"}